Howard Moore
Président chez NZeno Ltd.
Postes actifs de Howard Moore
Sociétés | Poste | Début | Fin |
---|---|---|---|
Pictor Ltd.
Pictor Ltd. BiotechnologyHealth Technology Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand. | Directeur des opérations | 10/08/2020 | - |
Directeur Général | - | 10/08/2020 | |
NZeno Ltd.
NZeno Ltd. Medical/Nursing ServicesHealth Services NZeno Ltd. produces safe pig kidneys that are compatible for human transplantation. The company was founded by Robert Bartlett Elliot, Olga Garkavenko and Paul Tan and is headquartered in Parnell, New Zealand. | Président | 01/01/2020 | - |
Cure Kids Ventures Ltd.
Cure Kids Ventures Ltd. Investment ManagersFinance Cure Kids Ventures Ltd (Cure Kids Ventures) is a venture capital subsidiary of Cure Kids founded in 2007. The firm is headquartered in Auckland, New Zealand. | Directeur/Membre du Conseil | 01/01/2008 | - |
Historique de carrière de Howard Moore
Anciens postes connus de Howard Moore
Sociétés | Poste | Début | Fin |
---|---|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Fondateur | 01/03/2004 | 01/03/2004 |
Corporate Officer/Principal | 01/03/2004 | 01/03/2004 |
Formation de Howard Moore
Massey University | Undergraduate Degree |
Statistiques
Internationale
Nouvelle-Zélande | 5 |
Etats-Unis | 2 |
Opérationnelle
Founder | 1 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Pictor Ltd.
Pictor Ltd. BiotechnologyHealth Technology Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand. | Health Technology |
NZeno Ltd.
NZeno Ltd. Medical/Nursing ServicesHealth Services NZeno Ltd. produces safe pig kidneys that are compatible for human transplantation. The company was founded by Robert Bartlett Elliot, Olga Garkavenko and Paul Tan and is headquartered in Parnell, New Zealand. | Health Services |
Cure Kids Ventures Ltd.
Cure Kids Ventures Ltd. Investment ManagersFinance Cure Kids Ventures Ltd (Cure Kids Ventures) is a venture capital subsidiary of Cure Kids founded in 2007. The firm is headquartered in Auckland, New Zealand. | Finance |
- Bourse
- Insiders
- Howard Moore
- Expérience